• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

香料中活性成分的地理变异性作为阿拉斯加境内分布和制造机制的指标。

Geographic Variability of Active Ingredients in Spice as an Indicator of Mechanisms of Distribution and Manufacture Within Alaska.

作者信息

Emery Dakota W, Iceman Christopher R, Hayes Sarah M

机构信息

Department of Chemistry and Biochemistry, University of Alaska Fairbanks, 505 S. Chandalar Dr, Fairbanks AK 99775.

Valparaiso University, 1700 Chapel Dr, Valparaiso IN 46383.

出版信息

J Young Investig. 2018 Apr;34(4):7-16. doi: 10.22186/jyi.34.4.7-16. Epub 2018 Apr 1.

DOI:10.22186/jyi.34.4.7-16
PMID:30405322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6217825/
Abstract

Designer drugs, like Spice, are synthetic psychoactive analogs of illegal substances with understudied health effects since they have traditionally been sold in packages labeled "not for human consumption" and the molecular structures can be specifically altered to circumvent legislation. Recent legislation has focused on regulating packaging and has reduced, but not eliminated, the distribution of Spice in Alaska. Legally obtained Spice samples from three geographic regions in Alaska were analyzed using liquid injection gas chromatography-mass spectrometry (GC-MS). Most (70%) of the samples contained illegal cannabinoids that have been regulated by the Drug Enforcement Agency and 47% contained multiple active ingredients. We hypothesized that the heterogeneity of the active ingredients between brands and across regions could be used to indicate small- or larger-scale manufacturing, and the results indicate multiple manufacturing scales. Evidence for small-scale manufacturing included inconsistent packaging, several of which contained similar active ingredient profiles in different brands purchased from a single store. Evidence for large-scale production was also found with some brands having consistent active ingredient profiles across regions. This study provides preliminary data for the geographic variability of active ingredients in Spice as an indicator of mechanisms of manufacture and distribution to inform legislators and law enforcement and help prioritizing resource allocation in an effort to quell Spice use in Alaska.

摘要

合成毒品,如香料(Spice),是非法物质的合成精神活性类似物,因其传统上以“非人类食用”标签包装出售,且分子结构可特意改变以规避立法,故而对其健康影响的研究较少。最近的立法聚焦于规范包装,这减少了但并未消除香料在阿拉斯加的流通。使用液体进样气相色谱 - 质谱联用仪(GC - MS)对从阿拉斯加三个地理区域合法获取的香料样本进行了分析。大多数(70%)样本含有已被美国缉毒局管制的非法大麻素,47%的样本含有多种活性成分。我们推测不同品牌以及不同区域之间活性成分的异质性可用于指示小规模或大规模制造,结果表明存在多种制造规模。小规模制造的证据包括包装不一致,其中一些从单一商店购买的不同品牌含有相似的活性成分谱。在一些品牌跨区域具有一致的活性成分谱的情况中也发现了大规模生产的证据。本研究提供了香料中活性成分地理变异性的初步数据,以此作为制造和分销机制的指标,为立法者和执法部门提供信息,并有助于在努力遏制阿拉斯加香料使用的过程中优先进行资源分配。

相似文献

1
Geographic Variability of Active Ingredients in Spice as an Indicator of Mechanisms of Distribution and Manufacture Within Alaska.香料中活性成分的地理变异性作为阿拉斯加境内分布和制造机制的指标。
J Young Investig. 2018 Apr;34(4):7-16. doi: 10.22186/jyi.34.4.7-16. Epub 2018 Apr 1.
2
[Spice in France: mixed herbs containing synthetic cannabinoids].[法国的香料:含合成大麻素的混合草药]
Ann Biol Clin (Paris). 2012 Jul-Aug;70(4):413-22. doi: 10.1684/abc.2012.0728.
3
[Spice drugs: cannabinoids as a new designer drugs].[香料药物:大麻素作为新型合成毒品]
Adicciones. 2009;21(3):181-6.
4
DNA sequence analyses of blended herbal products including synthetic cannabinoids as designer drugs.包含合成大麻素的混合草药产品的 DNA 序列分析。
Forensic Sci Int. 2013 Apr 10;227(1-3):33-41. doi: 10.1016/j.forsciint.2012.09.006. Epub 2012 Oct 23.
5
The impact of changes in UK classification of the synthetic cannabinoid receptor agonists in 'Spice'.英国对“香料”中合成大麻素受体激动剂的分类变化的影响。
Int J Drug Policy. 2011 Jul;22(4):274-7. doi: 10.1016/j.drugpo.2011.02.006. Epub 2011 Apr 8.
6
Variation in commercial smoking mixtures containing third-generation synthetic cannabinoids.含有第三代合成大麻素的商业吸烟混合物的差异。
Drug Test Anal. 2017 Feb;9(2):327-333. doi: 10.1002/dta.1975. Epub 2016 May 10.
7
Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.监测可能含有合成大麻素的草药混合物作为精神活性化合物。
J Mass Spectrom. 2010 Oct;45(10):1186-94. doi: 10.1002/jms.1811.
8
Synthetic Cannabinoid and Mitragynine Exposure of Law Enforcement Agents During the Raid of an Illegal Laboratory - Nevada, 2014.2014年内华达州一次非法实验室突袭行动中执法人员接触合成大麻素和米他加林的情况
MMWR Morb Mortal Wkly Rep. 2017 Dec 1;66(47):1291-1294. doi: 10.15585/mmwr.mm6647a3.
9
Identification and quantification of synthetic cannabinoids in 'spice-like' herbal mixtures: Update of the German situation in summer 2018.“香料类”草本混合物中合成大麻素的鉴定与定量:2018年夏季德国情况的更新
Forensic Sci Int. 2019 Jan;294:96-102. doi: 10.1016/j.forsciint.2018.11.001. Epub 2018 Nov 15.
10
Identification and quantification of synthetic cannabinoids in "spice-like" herbal mixtures: Update of the German situation for the spring of 2016.“香料类”草本混合物中合成大麻素的鉴定与定量:2016年春季德国情况的更新
Forensic Sci Int. 2016 Dec;269:31-41. doi: 10.1016/j.forsciint.2016.10.023. Epub 2016 Nov 4.

引用本文的文献

1
Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a ynthetic cannabinoid (SCB).人 vs. 人工合成大麻:一例因合成大麻素K2导致的药物性后部可逆性脑病综合征(PRES)病例
J Community Hosp Intern Med Perspect. 2020 Aug 2;10(4):361-364. doi: 10.1080/20009666.2020.1781349.

本文引用的文献

1
Increase in Adverse Reactions Associated with Use of Synthetic Cannabinoids - Anchorage, Alaska, 2015-2016.与合成大麻素使用相关的不良反应增加-阿拉斯加安克雷奇,2015-2016 年。
MMWR Morb Mortal Wkly Rep. 2016 Oct 14;65(40):1108-1111. doi: 10.15585/mmwr.mm6540a4.
2
Synthetic cannabinoids 2015: An update for pediatricians in clinical practice.2015年合成大麻素:临床实践中给儿科医生的最新信息
World J Clin Pediatr. 2016 Feb 8;5(1):16-24. doi: 10.5409/wjcp.v5.i1.16.
3
Severe Illness Associated with Reported Use of Synthetic Cannabinoids - Mississippi, April 2015.与使用合成大麻素相关的严重疾病-密西西比州,2015 年 4 月。
MMWR Morb Mortal Wkly Rep. 2015 Oct 9;64(39):1121-2. doi: 10.15585/mmwr.mm6439a7.
4
Notes from the Field: Increase in Reported Adverse Health Effects Related to Synthetic Cannabinoid Use - United States, January-May 2015.实地报告:2015年1月至5月美国与使用合成大麻素相关的不良健康影响报告增加
MMWR Morb Mortal Wkly Rep. 2015 Jun 12;64(22):618-9.
5
Notes from the field: severe illness associated with reported use of synthetic marijuana - Colorado, August-September 2013.现场记录:与报告的使用合成大麻素相关的严重疾病-科罗拉多州,2013 年 8 月至 9 月。
MMWR Morb Mortal Wkly Rep. 2013 Dec 13;62(49):1016-7.
6
Notes from the field: Severe illness associated with synthetic cannabinoid use - Brunswick, Georgia, 2013.现场记录:与合成大麻素使用相关的严重疾病-佐治亚州不伦瑞克,2013 年。
MMWR Morb Mortal Wkly Rep. 2013 Nov 22;62(46):939.
7
Acute kidney injury associated with synthetic cannabinoid use--multiple states, 2012.与合成大麻素使用相关的急性肾损伤——多个州,2012 年。
MMWR Morb Mortal Wkly Rep. 2013 Feb 15;62(6):93-8.
8
DNA sequence analyses of blended herbal products including synthetic cannabinoids as designer drugs.包含合成大麻素的混合草药产品的 DNA 序列分析。
Forensic Sci Int. 2013 Apr 10;227(1-3):33-41. doi: 10.1016/j.forsciint.2012.09.006. Epub 2012 Oct 23.
9
Designer drugs: a medicinal chemistry perspective.设计药物:从药物化学角度来看。
Ann N Y Acad Sci. 2012 Feb;1248:18-38. doi: 10.1111/j.1749-6632.2011.06199.x. Epub 2011 Nov 17.
10
The emergence and analysis of synthetic cannabinoids.合成大麻素的出现与分析。
Drug Test Anal. 2011 Jul-Aug;3(7-8):466-78. doi: 10.1002/dta.268. Epub 2011 Feb 21.